GH Research Plc (GHRS)

28.23 +0.31 (+1.11%) USD  |  NASDAQ  |  Sep 04, 16:00
28.56 +0.33 (+1.17%) Pre-Market: 08:24
More

GH Research Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for GHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Start Trial.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Atai Beckley, Inc. Upgrade
Avadel Pharmaceuticals Plc --
Jazz Pharmaceuticals Plc Upgrade
Eli Lilly & Co. Upgrade
Perrigo Co. Plc Upgrade